Last night, before the investor meeting in Redmond, a collection of investors -- representing lots of shares -- got together for dinner.
One comment struck me, at the time and gave food for thought for the rest of the evening.
"Microvision is a lot like a biotech." Investing in it is a lot like investing in a Biotech company.
In that Biotech companies, investors invest a lot of money with no guarantees that it will meet approval, etc, but that if it does... the returns are huge.
Sure there haven't been earnings, but if we compare to a biotech company, this company has the equivalent of a cure for cancer -- and also a side-effect free cure for obesity --electronics version.
The near eye display has the potential to change cure sore necks by putting the display front and center when you're standing up, and the LiDAR to prevent accidents, and serve numerous other functions by allowing machinery to see.
Not delivering income at the moment is problematic for investors, of course. But there is solid value under that.
